NCT04919642 — "Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma" trial site landscape

Public-registry site landscape for NCT04919642, “Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma”, a Cholangiocarcinoma study sponsored by TransThera Sciences (Nanjing), Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT04919642 (registry record)
Study title	Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
Official title	A Phase II, Open Label, Multicenter Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) Tablet in Adult Patients With Advanced Cholangiocarcinoma
Sponsor	TransThera Sciences (Nanjing), Inc.
Condition(s)	Cholangiocarcinoma; FGFR2 Fusion; FGFR2 Gene Mutation; FGFR1 Alteration
Phase	PHASE2
Listed sites	32
Site countries	United States

Patient-friendly overview of this study: eichor.com/study/NCT04919642.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT04919642 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related trials

Other Cholangiocarcinoma trials

← Eichor home · All tracked trials · Cholangiocarcinoma studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →